Prices as of 2025-11-25 16:15:34 ET
Ticker Appearances
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Commodity breakout worth paying attention to
NEAR-TERM US EQUITY TRENDS ARE BULLISH, BUT I EXPECT EQUITIES HAVE ENTERED A CHOPPIER ENVIRONMENT, WHICH MIGHT REQUIRE SOME CONSOLIDATION BEFORE SPX CAN PUSH BACK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Minor Bond yield breakout results in SPX selloff to near support
I CONTINUE TO SEE THE US STOCK MARKET AS BEING ATTRACTIVE, TECHNICALLY SPEAKING, AND DO NOT FEEL SUFFICIENT RISK IS THERE TO WARRANT A SELLOFF...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Pharmaceutical stocks look attractive
MARKETS HAVE ENTERED A WINDOW WHERE A POTENTIAL LOW COULD TAKE PLACE THIS WEEK (LIKELY WEDNESDAY-FRIDAY OF THIS WEEK). US DOLLAR AND US TREASURY YIELDS...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Defensive trading dominates as Pharma, & Utilities break out
Similar to Tuesday’s mild “down day,” Wednesday’s pullback failed to show sufficient deterioration to expect much follow-through just yet. The key driver of this rally,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Healthcare should soon hit support and reverse in February
January’s strong gains suggest that the bullish Pre-election year seasonality trends likely outweigh the bearish forecasts about how dismal earnings should be, and the NASDAQ...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Commodity breakout worth paying attention to
NEAR-TERM US EQUITY TRENDS ARE BULLISH, BUT I EXPECT EQUITIES HAVE ENTERED A CHOPPIER ENVIRONMENT, WHICH MIGHT REQUIRE SOME CONSOLIDATION BEFORE SPX CAN PUSH BACK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Minor Bond yield breakout results in SPX selloff to near support
I CONTINUE TO SEE THE US STOCK MARKET AS BEING ATTRACTIVE, TECHNICALLY SPEAKING, AND DO NOT FEEL SUFFICIENT RISK IS THERE TO WARRANT A SELLOFF...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Pharmaceutical stocks look attractive
MARKETS HAVE ENTERED A WINDOW WHERE A POTENTIAL LOW COULD TAKE PLACE THIS WEEK (LIKELY WEDNESDAY-FRIDAY OF THIS WEEK). US DOLLAR AND US TREASURY YIELDS...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Defensive trading dominates as Pharma, & Utilities break out
Similar to Tuesday’s mild “down day,” Wednesday’s pullback failed to show sufficient deterioration to expect much follow-through just yet. The key driver of this rally,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Healthcare should soon hit support and reverse in February
January’s strong gains suggest that the bullish Pre-election year seasonality trends likely outweigh the bearish forecasts about how dismal earnings should be, and the NASDAQ...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Commodity breakout worth paying attention to
NEAR-TERM US EQUITY TRENDS ARE BULLISH, BUT I EXPECT EQUITIES HAVE ENTERED A CHOPPIER ENVIRONMENT, WHICH MIGHT REQUIRE SOME CONSOLIDATION BEFORE SPX CAN PUSH BACK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
Daily Technical Strategy
Minor Bond yield breakout results in SPX selloff to near support
I CONTINUE TO SEE THE US STOCK MARKET AS BEING ATTRACTIVE, TECHNICALLY SPEAKING, AND DO NOT FEEL SUFFICIENT RISK IS THERE TO WARRANT A SELLOFF...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: cddf0d-c0636b-17d00c-927a43-7b31ef Array ( [cookie] => cddf0d-c0636b-17d00c-927a43-7b31ef [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.36 )
